Gene Editing
Neurogenetic Disorders
Translational Dermatology

At the Garin-Shkolnik Laboratory, we investigate the molecular mechanisms underlying neurological and dermatological diseases, translating scientific discoveries into innovative therapeutic strategies. Led by Dr. Tali Garin-Shkolnik, MD, PhD, at Rambam Health Care Campus, our research combines molecular genetics, advanced gene-editing technologies, cellular biology, and clinical insight to address important unmet medical needs. From understanding disease mechanisms to developing tomorrow's targeted therapies.

Garin-Shkolnik Laboratory

Developing Genetic and Molecular Therapies

for Neurological and Skin Disease
Gene Editing  •  Neurogenetic Disorders  •  Translational Dermatology
Our Mission

From Disease Mechanisms to New Therapies

The Garin-Shkolnik Laboratory is a translational research group developing innovative therapies for severe neurological and dermatological diseases. We combine molecular research, advanced genome-editing technologies, disease models and clinical insight to translate scientific discoveries into meaningful therapeutic strategies.

Our Research

Two Translational Research Programs

Flagship Program

Gene Therapy & Genome Editing

We develop precision genetic therapies for severe neurogenetic disorders, with a major focus on GRIN2B-related neurodevelopmental disorders.

Our work emphasizes next-generation genome-editing technologies capable of correcting disease-causing variants directly at the DNA level.

  • Prime editing
  • Base editing
  • CRISPR-based genome engineering
  • GRIN2B-related disorders
  • Other monogenic neurological disorders
  • Patient-derived disease models
  • Neuronal and organoid models
  • Therapeutic delivery strategies
Explore Gene Therapy Research
Translational Dermatology

Psoriasis & Cutaneous T-Cell Lymphoma

We investigate molecular and cellular mechanisms underlying chronic inflammatory and neoplastic skin diseases and use these discoveries to develop new therapeutic strategies.

Primary research areas:

  • Psoriasis
  • Mycosis fungoides (MF)
  • Cutaneous T-cell lymphoma (CTCL)
  • T-cell biology
  • Keratinocyte biology
  • Disease persistence and recurrence
  • Novel molecular therapeutic targets
Explore Dermatology Research
Current Focus

Featured Research Programs

01 / NEUROGENETICS

GRIN2B

Developing genetic therapies for GRIN2B-related neurodevelopmental disorders.

Learn more →
02 / GENE EDITING

Prime & Base Editing

Applying next-generation genome-editing technologies to precisely correct disease-causing genetic variants.

Learn more →
03 / DERMATOLOGY

Psoriasis

Investigating mechanisms responsible for persistent inflammation, disease recurrence and therapeutic response.

Learn more →
04 / CUTANEOUS ONCOLOGY

Mycosis Fungoides

Exploring malignant T-cell biology and new therapeutic strategies for mycosis fungoides and CTCL.

Learn more →
Our Approach

Discovery → Validation → Therapy

Clinical observations guide the questions we investigate. We combine molecular biology, cellular systems, disease models and advanced therapeutic technologies to move promising discoveries toward clinical translation.

Patients
Disease Models
Mechanisms
Targets
Experimental Therapy
Translation
Science

Selected Publications

Explore recent publications from the Garin-Shkolnik Laboratory and our collaborating research groups.

View Publications
People

Meet Our Team

Our multidisciplinary team brings together expertise in dermatology, molecular biology, genome editing, neurobiology, disease modelling and translational medicine.

Meet the Team
Latest

News & Highlights

Publication

Latest Research

Recent publications and scientific discoveries from the lab.

Read more →
Research

Research Milestones

New developments across our gene-editing and dermatology programs.

Read more →
Lab

Lab Updates

Grants, conferences, collaborations and new members of our team.

Read more →
Opportunities

Join Our Lab

We welcome highly motivated students and researchers interested in translational biomedical research and the development of new therapies.

Gene TherapyPrime EditingBase EditingNeurogeneticsGRIN2BPsoriasisCTCLMolecular Dermatology
View Open Positions

Garin-Shkolnik Laboratory

Department of Dermatology
Rambam Health Care Campus
Haifa, Israel

Contact Us

Translational Dermatology Research